BioPharma
In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...
November 01, 2024 | Interview
In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...
October 17, 2024 | Interview
Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...
October 11, 2024 | News
SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bio...
October 08, 2024 | News
The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility together with a customer experience lab. Operations of the...
October 01, 2024 | News
Additions to sites in Cincinnati, Ohio, and Bend, Ore. broaden early development capabilities to help accelerate pre-clinical oral drug product innovation ...
September 27, 2024 | News
New Pharmaceutical Auxiliary Materials cGMP standard introduced for cell culture media manufacturing Merck first in the industry to receive EXCiPACT&nbs...
September 06, 2024 | News
In an exclusive interview with BioPharma APAC, Rehan Saghir, Executive Vice President of ZP Therapeutics, Zuellig Pharma shares his expert insights...
August 20, 2024 | News
· Melbourne manufacturing site to be one of the most advanced pharmaceutical production facilities in Austr...
August 06, 2024 | News
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
July 22, 2024 | News
Merck Life Science is thrilled to announce the commencement of commercial production at our first Good Manufacturing Practice (GMP) compliant manuf...
July 16, 2024 | News
In an interview with BioPharma APAC, Ashok Kumar, Head of BIO4C Commercial at Merck Life Science (Asia Pacific), shares insights on what se...
June 24, 2024 | Interaction
Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR mutations s...
June 10, 2024 | News
Alphamab Oncology announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. , a wholly-owned subsidiary of the Company, entered into a research an...
June 06, 2024 | News
Most Read
Bio Jobs
News
Editor Picks